People | Locations | Statistics |
---|---|---|
Naji, M. |
| |
Motta, Antonella |
| |
Aletan, Dirar |
| |
Mohamed, Tarek |
| |
Ertürk, Emre |
| |
Taccardi, Nicola |
| |
Kononenko, Denys |
| |
Petrov, R. H. | Madrid |
|
Alshaaer, Mazen | Brussels |
|
Bih, L. |
| |
Casati, R. |
| |
Muller, Hermance |
| |
Kočí, Jan | Prague |
|
Šuljagić, Marija |
| |
Kalteremidou, Kalliopi-Artemi | Brussels |
|
Azam, Siraj |
| |
Ospanova, Alyiya |
| |
Blanpain, Bart |
| |
Ali, M. A. |
| |
Popa, V. |
| |
Rančić, M. |
| |
Ollier, Nadège |
| |
Azevedo, Nuno Monteiro |
| |
Landes, Michael |
| |
Rignanese, Gian-Marco |
|
Banerjee, Atanu
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (1/1 displayed)
Places of action
Organizations | Location | People |
---|
article
A Series of Non-Oxido VIVComplexes of Dibasic ONS Donor Ligands
Abstract
<p>A series of mononuclear non-oxido vanadium(IV) complexes, [V<sup>IV</sup>(L<sup>1-4</sup>)<sub>2</sub>] (1-4), featuring tridentate bi-negative ONS chelating S-alkyl/aryl-substituted dithiocarbazate ligands H<sub>2</sub>L<sup>1-4</sup>, are reported. All the synthesized non-oxido V<sup>IV</sup>compounds are characterized by elemental analysis, spectroscopy (IR, UV-vis, and EPR), ESI-MS, as well as electrochemical techniques (cyclic voltammetry). Single-crystal X-ray diffraction studies of 1-3 reveal that the mononuclear non-oxido V<sup>IV</sup>complexes show distorted octahedral (1 and 2) or trigonal prismatic (3) arrangement around the non-oxido V<sup>IV</sup>center. EPR and DFT data indicate the coexistence of mer and fac isomers in solution, and ESI-MS results suggest a partial oxidation of [V<sup>IV</sup>(L<sup>1-4</sup>)<sub>2</sub>] to [V<sup>V</sup>(L<sup>1-4</sup>)<sub>2</sub>]<sup>+</sup>and [V<sup>V</sup>O<sub>2</sub>(L<sup>1-4</sup>)]<sup>-</sup>therefore, all these three complexes are plausible active species. Complexes 1-4 interact with bovine serum albumin (BSA) with a moderate binding affinity, and docking calculations reveal non-covalent interactions with different regions of BSA, particularly with Tyr, Lys, Arg, and Thr residues. In vitro cytotoxic activity of all complexes is assayed against the HT-29 (colon cancer) and HeLa (cervical cancer) cells and compared with the NIH-3T3 (mouse embryonic fibroblast) normal cell line by MTT assay and DAPI staining. The results suggest that complexes 1-4 are cytotoxic in nature and induce cell death in the cancer cell lines by apoptosis and that a mixture of V<sup>IV</sup>, V<sup>V</sup>, and V<sup>V</sup>O<sub>2</sub>species could be responsible for the biological activity.</p>